ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

IGE Image Scan Holdings Plc

1.35
0.00 (0.00%)
10 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Image Scan Holdings Plc LSE:IGE London Ordinary Share GB0031410581 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1.35 1.20 1.50 1.35 1.35 1.35 8,180 07:36:25
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Photographic Equip & Supply 2.96M 124k 0.0009 15.00 1.85M
Image Scan Holdings Plc is listed in the Photographic Equip & Supply sector of the London Stock Exchange with ticker IGE. The last closing price for Image Scan was 1.35p. Over the last year, Image Scan shares have traded in a share price range of 1.05p to 2.55p.

Image Scan currently has 136,854,577 shares in issue. The market capitalisation of Image Scan is £1.85 million. Image Scan has a price to earnings ratio (PE ratio) of 15.00.

Image Scan Share Discussion Threads

Showing 6351 to 6374 of 7125 messages
Chat Pages: Latest  261  260  259  258  257  256  255  254  253  252  251  250  Older
DateSubjectAuthorDiscuss
19/11/2019
13:36
Well there you go, rather a mischievous exaggeration! Made it sound like head technologist was ill not had an accident and was already back in part time ! Chief Software engineer? No , a team member but not the grand fromage at all.

So why would you want to stir things up Msr Reynard. Not Renard then or would that be too obvious! Vive le difference!

assagai
19/11/2019
13:01
Don't know Monty but this guy only joined ADVFN today so likely an insider? I will call Bill.
assagai
19/11/2019
12:28
Where did this information come from
monty68
19/11/2019
08:45
Curious. Chief software guy leaves and head Technologist long term sick. Price goes up. Well that's AIM for you.
reynard4
18/11/2019
10:15
Appologies for the earlier company mix up. I follow both IGE and IQE.
plutonian
18/11/2019
10:01
Well done Bill. Wish I knew why though.
paleje
18/11/2019
09:32
Volume's keen
owenski
18/11/2019
09:29
Well on its way now and a great Monday morning start.
clocktower
18/11/2019
09:12
LOL! That TU is for IQE!
soldi
18/11/2019
09:08
No - wrong co!

That's IQE not IGE!

philjeans
18/11/2019
08:59
[edit - sorry wrong company]

Trading update out...

plutonian
18/11/2019
08:44
Going well today again - been tipped?
philjeans
15/11/2019
15:01
Not much chance of death Assagai, all the signals seem positive, and I expect to see this at least double again in the near future.
clocktower
15/11/2019
14:53
SP back to where it was in 2016

If they can get on and just sell product then this'll still look cheap. Time will tell. imo

owenski
15/11/2019
14:37
I guess it's do or die......
assagai
15/11/2019
14:26
Brave man, Assagai. I have too many to think of adding more, and I don't suppose i have a small fraction of your holding!
gnnmartin
15/11/2019
14:22
I have☺️
assagai
15/11/2019
13:05
More deals in the pipeline?

Good time to add.

philjeans
15/11/2019
13:01
About time too
monty68
15/11/2019
12:27
This insists on going up admittedly on weak volume, doubled since early Oct.
paleje
29/10/2019
16:46
Hopefully not long before the next leg up.
clocktower
27/10/2019
16:33
Please see SKIN - about to move up.

1) Laboratory grown human skin that can be tested on, instead of testing on animals
2) Only commercially available option of its type.
3) Exploiting high growth technologies such as Artificial Intelligence
4) Human skin cloning duplicates test subjects
5) It is an Ethical investment
6) Exploiting CBD market
7) Cutting edge Woundcare -Visual diagnostic wound dressing that changes colour to indicate infection or improvement of the wound under the dressing.
8) Expanding laboratory space by 100% to accommodate the rate of growth due to be RNS any day
9) Currently negotiating further contracts. (8 CBD we know of and others) due to be RNS soon
10) Fully funded - The growth of the Company has been so well supported and received by
the market that all corporate activity has been achieved, funding in place to accommodate the continued growth.
11) Meeting its objective of increasing the average revenue per client as it evolves into a multiple revenue stream product and services company
12) Four Blue-Chip (US and EU) client agreements signed
13) owns 9.35% of Cellulac plc
14) Algzym - A patented enzyme-based technology which bursts algal cell walls and releases Omega 3 oils in a simple solvent-free process.
15) Company moving forward at a rapid pace.
16) Major relationships already built with billion-dollar companies
17) Sales routes for products already in place in multiple countries
18) EU laws changing to force companies to stop beauty and pharmaceuticals testing on animals.
19) EU laws changing to force companies to stop making claims they can't back up scientifically.
20) EU laws changing to force companies to comply with more rigorous testing before market launch.
21) Presenting at major US and European Skin and Dermatology events
22) Presenting at major CBD Exhibitions
23) Strong, dynamic and driven board
24) CEO is an owner of company/major investor

The chart is primed for a great entry'
hxxps://www.labskin.co.uk/

lisae123
26/10/2019
00:07
No, good point Assagai. Whilst I think the closed period only strictly relates to insider trading, you're probably right, probably not likely to release any further contract news until the results.So six weeks or so of speculation and rumour. :o)
laugher
25/10/2019
22:55
We won't find anything out on Monday I'm afraid apart from how long the Brexit extension is!
Remember the last update was a "pre close" trading statement I. E. We are now in a closed period....

assagai
Chat Pages: Latest  261  260  259  258  257  256  255  254  253  252  251  250  Older